#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Sexually transmitted disease Neuropathy peripheral Cold type haemolytic anaemia Hypoparathyroidism Diabetes insipidus Frostbite Oesophageal squamous cell carcinoma stage III B-cell lymphoma Thrombocytopenia Cutaneous T-cell lymphoma stage II B-cell small lymphocytic lymphoma refractory Optic glioma Enteritis Lung adenocarcinoma Neutropenia More trials…

    Learn about Rare Diseases

    Leiomyosarcoma metastatic – Life with Disease Alexander disease – Life with Disease Mantle cell lymphoma stage II Synovial sarcoma metastatic Lymphatic malformation – Life with Disease Congenital hypotransferrinaemia – Trials in Disease Hereditary angioedema – Basic Information Noonan syndrome – Basic Information Ornithine transcarbamoylase deficiency – Diagnostics Leiomyosarcoma metastatic – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Candesartan Ketamine Hydrochloride Prax-628 Liraglutide Sitravatinib Malate Ecoo2 Ampicillin Sodium Nelivaptan Tamuzimod Acetate Quetiapine Buserelin Acetate Interferon Alfa Tolinapant Lactate Pemetrexed Imifoplatin Resamirigene Bilparvovec Macitentan Trometamol SODIUM BENZOATE Io103 Acetate More therapies…

    Learn about Your Condition

    Neuromuscular scoliosis Skin neoplasm excision Inner ear disorder Albuminuria Pseudoxanthoma elasticum Ulcerative keratitis Colorectal cancer stage III Vulval cancer recurrent Small cell carcinoma Left ventricular dysfunction Lymphangioleiomyomatosis Hypoparathyroidism Mitochondrial myopathy Haematological infection Fungal infection More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Nervous System Diseases

  • Study on Brain Imaging for Alzheimer’s Disease Using Florquinitau (18F) in Patients with Mild Cognitive Impairment and Early Alzheimer’s Symptoms

    Recruiting

    4 1 1
    Investigated Diseases:
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • Florquinitau (18F)
    Belgium

  • Comparison of Three PET Tau Tracers ([18F]RO948, [18F]PI2620, and [18F]MK-6240) in People with Cognitive Impairment

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Cognitive disorder
    Investigated Drugs:
    • 2-(6-[18F]Fluoro-Pyridin-3-Yl)-9H-Dipyrido[2,3-B:3′,4′-D]Pyrrole
    • Flutemetamol (18F)
    • Izaflortaucipir (18F)
    Spain

  • Study on How Bevacizumab Affects the Immune System in Patients with Glioblastoma Multiforme

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Glioblastoma multiforme
    Investigated Drugs:
    • Bevacizumab
    Hungary

  • Study on the Safety and Effects of DNL593 for Patients with Frontotemporal Dementia

    Recruiting

    2 1 1
    Investigated Diseases:
    • Frontotemporal dementia
    Investigated Drugs:
    • DNL593
    • Famotidine
    Belgium Czechia France Italy The Netherlands Portugal +1

  • Study on Flutemetamol (18F) for Detecting Amyloid Pathology in Cognitively Normal Elderly at Risk for Alzheimer’s Disease

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • Flutemetamol (18F)
    The Netherlands

  • Study on Eptinezumab for Migraine: Understanding How It Works and Finding Patient Response Markers for Migraine Sufferers

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Migraine
    Investigated Drugs:
    • Eptinezumab
    Italy
Previous Page
1 … 15 16 17 18 19 … 141
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!